Frequently, medicinal development has focused on minute molecules, but amino acid partners are rapidly receiving attention. This novel strategy embraces combining peptides with alternative medicinal techniques to confront intricate disease targets. By employing the distinctive properties of peptides – such as high precision and bioavailability �